NRG GI005 Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)

January 19, 2021
https://www.clinicaltrials.gov/ct2/show/NCT04068103
Cancer - Colorectal
Principal Investigator: Eleanor M Walker, MD
CANCER, COLON, COLON CANCER
Accepting Participants